These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15238856)
41. [Interrelations between systemic and focal scleroderma in children]. Uvarova NN; Vlasova TM Pediatriia; 1983 Nov; (11):46-8. PubMed ID: 6669434 [No Abstract] [Full Text] [Related]
42. [Clinico-encephalographic examination in systemic and focal scleroderma]. Kochetov DP; Dvoĭnikov ND; Gorlanova LI Vestn Dermatol Venerol; 1977 Jul; (7):33-7. PubMed ID: 899234 [No Abstract] [Full Text] [Related]
43. [Comparative study of focal (skin) and systemic forms of scleroderma]. Monakhov KN; Raznatovskiĭ IM Revmatologiia (Mosk); 1988; (3):36-9. PubMed ID: 3065893 [No Abstract] [Full Text] [Related]
44. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease. Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084 [TBL] [Abstract][Full Text] [Related]
47. When is scleroderma not scleroderma? The differential diagnosis of progressive systemic sclerosis. Rodnan GP Bull Rheum Dis; 1981; 31(2):7-10. PubMed ID: 6086004 [No Abstract] [Full Text] [Related]
48. Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). Scheja A; Akesson A; Geborek P; Wildt M; Wollheim CB; Wollheim FA; Vischer UM Arthritis Res; 2001; 3(3):178-82. PubMed ID: 11299058 [TBL] [Abstract][Full Text] [Related]
49. [News about scleroderma: survey of present state of research problems (author's transl)]. Stáva Z; Kobíková M; Kolár J; Drugová B Cas Lek Cesk; 1974; 113(26):787-92. PubMed ID: 4844781 [No Abstract] [Full Text] [Related]
50. [Scleroatrophic lichen and its relation to scleroderma]. Kalamkarian AA; Fedorova EG Vestn Dermatol Venerol; 1982; (12):4-7. PubMed ID: 7158014 [No Abstract] [Full Text] [Related]
51. Localized scleroderma and systemic sclerosis: is there a connection? Gupta RA; Fiorentino D Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859 [TBL] [Abstract][Full Text] [Related]
56. [Linear scleroderma in children (apropos of 27 cases)]. Larrègue M; Ziegler JE; Lauret P; Bonafe J; Lorette G; Titi A; Ramdenee P; Bressieux JM Ann Dermatol Venereol; 1986; 113(3):207-24. PubMed ID: 3752860 [TBL] [Abstract][Full Text] [Related]
57. Antinuclear antibodies and anti-DNA antibodies in scleroderma. A possible relationship between joint manifestations and increased antibodies in localized scleroderma. Serup J; Staun-Olsen P Allergy; 1986 Aug; 41(6):452-6. PubMed ID: 3491549 [TBL] [Abstract][Full Text] [Related]
58. [Scleroderma, an ageing process? I. Clinical and immunological aspects (author's transl)]. Sandhofer M; Fritz J; Altmann H Aktuelle Gerontol; 1977 Dec; 7(12):645-51. PubMed ID: 26229 [TBL] [Abstract][Full Text] [Related]
59. Finding the groove: The groove sign in scleroderma and related disorders. Gómez Gómez A; Cecconi A Vasc Med; 2017 Apr; 22(2):161. PubMed ID: 28429663 [No Abstract] [Full Text] [Related]
60. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate]. Lüthke K; Conrad K; Frank KH Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]